Literature DB >> 27904851

Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study.

Oh Kyoung Kwon1, Se Won Kim2, Hyun-Dong Chae3, Seung Wan Ryu4, Ho Young Chung1, Sang Woon Kim2, Won Kee Lee5, Wansik Yu1.   

Abstract

PURPOSE: We validate the 7th American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) staging system for gastric cancer and propose a new staging system that reflects the prognostic significances of each of T and N category.
METHODS: Data from 5,957 patients who underwent curative gastrectomies from 2000 to 2007 at 4 university hospitals in Daegu Metropolitan city in Korea were analyzed for the validation of the 7th AJCC/UICC staging system for gastric cancer. The hazard ratios of the respective T and N categories were estimated and converted to weightings and summated to make prognostic score (P-score). Homogeneity and stage grouping were determined according to the P-scores.
RESULTS: In the 7th AJCC/UICC staging system for gastric cancer, poor discrimination was noted between stages IIB and IIIA (P = 0.152). In addition, heterogeneity in stage IIB (P = 0.021) and a small gap in 5-year survival rates (1.7%) between stages IA and IB were noted. A new proposed staging system was generated on the basis of P-scores and demonstrated more discrimination between stages and more homogeneity within stages. The new staging system reflects the different prognostic impacts of N3a and N3b.
CONCLUSION: Several controversial issues of the 7th AJCC/UICC staging system for gastric cancer were reconfirmed in the present analysis. The TNM system based on P-score appears to be more scientifically accurate than the 7th AJCC/UICC staging system for gastric cancer.

Entities:  

Keywords:  Stomach neoplasms; TNM classification

Year:  2016        PMID: 27904851      PMCID: PMC5128375          DOI: 10.4174/astr.2016.91.6.295

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  22 in total

1.  The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: a case-control study.

Authors:  Kyong-Hwa Jun; Jeong-Sun Lee; Ji-Hyun Kim; Jin-Jo Kim; Hyung-Min Chin; Seung-Man Park
Journal:  Int J Surg       Date:  2014-07-12       Impact factor: 6.071

2.  Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.

Authors:  Jiping Wang; Ping Dang; Chandrajit P Raut; Prakash K Pandalai; Ugwuji N Maduekwe; David W Rattner; Gregory Y Lauwers; Sam S Yoon
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

Review 3.  Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Authors:  Jizhun Zhang; Yangbing Zhou; Kewei Jiang; Zhanlong Shen; Yingjiang Ye; Shan Wang
Journal:  Tumour Biol       Date:  2014-04-03

4.  Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?

Authors:  Manali I Patel; Kim F Rhoads; Yifei Ma; James M Ford; Brendan C Visser; Pamela L Kunz; George A Fisher; Daniel T Chang; Albert Koong; Jeffrey A Norton; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2012-11-13       Impact factor: 5.344

5.  Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system.

Authors:  Viktoria S Warneke; Hans-Michael Behrens; Jörg T Hartmann; Harald Held; Thomas Becker; Nicolas T Schwarz; Christoph Röcken
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

6.  Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma.

Authors:  Lee J McGhan; Barbara A Pockaj; Richard J Gray; Sanjay P Bagaria; Nabil Wasif
Journal:  J Gastrointest Surg       Date:  2011-10-05       Impact factor: 3.452

7.  Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Authors:  X-J Wu; R-L Miao; Z-Y Li; Z-D Bu; L-H Zhang; A-W Wu; X-L Zong; S-X Li; F Shan; X Ji; H Ren; J-F Ji
Journal:  Eur J Surg Oncol       Date:  2015-04-03       Impact factor: 4.424

8.  Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.

Authors:  Xiaobao Li; Yongfeng Liu; Bo Cao; Bin Liu; Tiecheng Bai; Xiaoyong Li; Leyuan Mei; Xiangming Che
Journal:  Hepatogastroenterology       Date:  2015 Mar-Apr

9.  Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.

Authors:  Luigi Marano; Virginia Boccardi; Bartolomeo Braccio; Giuseppe Esposito; Michele Grassia; Marianna Petrillo; Modestino Pezzella; Raffaele Porfidia; Gianmarco Reda; Angela Romano; Michele Schettino; Angelo Cosenza; Giuseppe Izzo; Natale Di Martino
Journal:  World J Surg Oncol       Date:  2015-07-16       Impact factor: 2.754

10.  Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer.

Authors:  Luigina Graziosi; Elisabetta Marino; Emanuel Cavazzoni; Annibale Donini
Journal:  World J Surg Oncol       Date:  2013-05-20       Impact factor: 2.754

View more
  7 in total

1.  Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.

Authors:  Y Wang; J Zhang; S Guo; Z Dong; X Meng; G Zheng; D Yang; Z Zheng; Y Zhao
Journal:  Clin Transl Oncol       Date:  2019-03-22       Impact factor: 3.405

2.  Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country.

Authors:  Alyson L Mahar; Brandon Zagorski; Daniel Kagedan; Matthew Dixon; Abraham El-Sedfy; Jovanka Vasilevska-Ristovska; Daniela Cortinovis; Corwyn Rowsell; Calvin Law; Lucy Helyer; Lawrence Paszat; Natalie Coburn
Journal:  Can J Public Health       Date:  2018-08-08

3.  Prognostic Factors in Stage IB Gastric Cancer after Surgical Resection.

Authors:  Byunghyuk Yu; Ji Yeon Park; Ki Bum Park; Oh Kyoung Kwon; Seung Soo Lee; Ho Young Chung
Journal:  J Gastric Cancer       Date:  2020-09-23       Impact factor: 3.720

4.  Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness.

Authors:  Xingwen Wang; Changshun Wu; Baoying Yuan; Dan Wang; Huiling Liu; Hong Feng; Shui Sun
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

5.  Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.

Authors:  Peng Jin; Xiaoyan Ji; Shuai Ma; Wenzhe Kang; Hao Liu; Yang Li; Fuhai Ma; Haitao Hu; Weikun Li; Yantao Tian
Journal:  J Cancer Res Clin Oncol       Date:  2020-08-09       Impact factor: 4.553

6.  Immunohistochemical Expression of CDX2 in Gastric Carcinoma.

Authors:  Ahmed Avan Sardar; Jalal Ali Jalal; Kalthuma Salih Hamad Ameen
Journal:  Iran J Pathol       Date:  2022-03-08

7.  Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant Protocols.

Authors:  Jeong Il Yu; Do Hoon Lim; Jeeyun Lee; Won Ki Kang; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Seung Tae Kim; Su Jin Lee; Sung Kim; Tae Sung Sohn; Jun Ho Lee; Ji Yeong An; Min Gew Choi; Jae Moon Bae; Heejin Yoo; Kyunga Kim
Journal:  Cancer Res Treat       Date:  2018-10-01       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.